FDA — authorised 1 July 1991
- Application: BLA019959
- Marketing authorisation holder: NOVO NORDISK INC
- Status: supplemented
FDA authorised Novolin N on 1 July 1991
Yes. FDA authorised it on 1 July 1991.
NOVO NORDISK INC holds the US marketing authorisation.